Patients Stem the bleeding: Rising to meet the growing demand for CGT... Following World Blood Donor Day, a look at the continued need for more donors of blood, but also cord blood and perinatal tissue, too.
R&D A playbook for effective sponsor/CRO partnership Find out more about optimising sponsor/CRO collaboration in an interview on a case study in FI cell therapy.
R&D Why pharma’s future may run through your local blood centre With demand for cell and gene therapies (CGTs) growing rapidly, blood centres are indispensable collaborators.
R&D Perspectives in viral clearance Since the 1990s, viral clearance (VC) studies have been a critical safety step for biologic drugs.
Partner Content Partner Content LEAN Cell & Gene Summit Boston Manufacturing Advanced Therapies Just in Time for All Patients
R&D Cell therapy transportation and storage with hydrogels Hydrogels are revolutionising cell therapy storage – discover how they tackle cold chain challenges and reduce costs while preserving cell viability.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.